 |
인쇄하기
취소
|
Allergan Korea faces damage suit
Hanall Pharm said on May 16 it has decided to seek 2.0 billion won in compensation from Allergan Korea for its defamed company image.
Hanall has marketed BTXA, which is in a direct competition with Allergan Korea's Botox, known globally as treatment for reducing wrinkles.
Botox was approved for medical use in the U.S. 14 years ago to treat eye movement disorders such as crossed eyes and u...
Hanall has marketed BTXA, which is in a direct competition with Allergan Korea's Botox, known globally as treatment for reducing wrinkles.
Botox was approved for medical use in the U.S. 14 years ago to treat eye movement disorders such as crossed eyes and u...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.